PepperLedger
COMPOUND LIBRARY·BIOREGULATOR SERIES·THYMALIN
◈ Part of the Bioregulator Series →
Also in the Bioregulator Series
COMPOUND PROFILE · PEPPERLEDGER

Thymalin

Khavinson et al. · Saint Petersburg Institute of Bioregulation and Gerontology
Type
Natural thymic peptide Cytomax — full spectrum of thymic peptides extracted from calf thymus gland
Class
Thymic immune regulator · T-cell restoration complex · Full-spectrum thymic bioregulator · Longevity compound
Administration
Subcutaneous injection · 5–10 mg/day for 5–10 days · Annual or biannual course
Half-life
Variable — natural peptide complex; cumulative effect with 6–12 month aftereffect characteristic of Cytomax formulations
Most studied use
Longevity core stack · Immune restoration · Thymic aging reversal · Annual preventive protocol
Regulatory status
Not FDA-approved · Used clinically in Russian gerontology practice for 30+ years · Research compound in Western markets
Human evidence
Most clinically studied thymic bioregulator — 10-year cohort showing 2-fold mortality reduction in elderly subjects. Observational, not RCT.
Preclinical evidence
Strong — T-cell maturation, IL-2 restoration, CD4/CD8 normalization across multiple animal models

EDUCATIONAL TOOL — NOT MEDICAL ADVICE

What is Thymalin?

Thymalin is a Cytomax — a natural extract containing the full spectrum of peptides from calf thymus gland. Unlike Vilon (the synthetic dipeptide KE), Thymalin delivers the complete thymic peptide fraction. It was developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology as the anchor compound for immune system restoration.

The thymus produces and matures T-lymphocytes — the cells at the center of adaptive immunity. From birth, the thymus is active and large; from early adulthood it begins involuting, progressively replaced by fat. By age 75, most people retain only 5–10% of functional thymic tissue. This is not a background fact about aging — it is arguably the central immune aging event, and Thymalin is designed to address it directly.

Thymalin is administered by subcutaneous injection in 5–10 day courses, typically once or twice yearly. The clinical data Khavinson generated over 10 years of follow-up makes it the bioregulator with the deepest human longevity dataset in the series.

How it works

Full Thymic Peptide Spectrum

Where Cytogens like Vilon deliver a single isolated peptide sequence, Thymalin provides the complete thymic peptide fraction. Khavinson's hypothesis is that this broader spectrum of thymic signaling molecules can more comprehensively restore thymic function — multiple parallel chromatin interactions across different immune cell gene expression programs.

T-Cell Restoration and Differentiation

Mechanistic studies show Thymalin promotes thymocyte differentiation into mature T-cells, restores CD4+/CD8+ ratios toward younger profiles, and upregulates IL-2 and interferon-gamma production — the foundational cytokines of adaptive immune function.

Downstream Immune System Effects

Because T-cells regulate B-cell function and NK cell activity, Thymalin's effects extend beyond the thymus itself. Observed downstream effects include improved antibody production, enhanced NK cell cytotoxicity, and normalization of autoimmune markers in some subjects. The thymus is a control node — restore it and you affect the whole system.

What the research shows

MOST SUBSTANTIAL HUMAN LONGEVITY DATASET IN THE BIOREGULATOR SERIES — OBSERVATIONAL, NOT RCT
STUDYAnnals of the New York Academy of Sciences · 2003

10-Year Longevity Trial with Annual Thymalin + Epithalon Courses

Khavinson VK, Morozov VG

Elderly subjects (60–80 years) receiving annual 5-day courses of Thymalin alongside Epithalon showed approximately 2-fold lower mortality over 10 years vs. controls. Improvements in immune markers (T-cell counts, NK activity, IL-2), cardiovascular parameters, and functional status were maintained across the treatment period.

View on PubMed →
STUDYGerontology · 1998

Thymalin in Post-Surgical Immunosuppression in Elderly Patients

Khavinson VK et al.

Thymalin administered to elderly surgical patients improved immune recovery post-operatively, reduced infection rates, and shortened hospital stay vs. controls. T-cell counts normalized faster in the Thymalin group — suggesting a practical clinical application beyond pure longevity use.

View on PubMed →
STUDYBulletin of Experimental Biology and Medicine · 2006

Thymalin and Lymphocyte Telomere Preservation

Khavinson VK et al.

Elderly subjects treated with Thymalin showed reduction in lymphocyte telomere shortening rates over the treatment period compared to untreated controls. Authors proposed immune cell preservation as a secondary pathway alongside Epithalon's direct telomerase activation.

View on PubMed →

Community knowledge

Thymalin is high on the biohacker priority list — frequently appearing alongside Epithalon as the foundational two-compound longevity stack. The 10-year human cohort data gives it unusual credibility compared to most research peptides, even accounting for the limitations. Community protocols generally follow Khavinson's clinical dosing: 5–10 mg/day for 5–10 days, once or twice yearly.

Stack patterns in the community pair Thymalin with Epithalon (annual course), Vesugen (vascular), and Endoluten (pineal). The Thymalin + Vilon combination is common — Thymalin for the annual course, Vilon for shorter maintenance windows between. Some users report subjective immune improvements within days; others report more gradual effects over weeks.

WHAT THE RESEARCH SHOWS
KNOWN
  • Thymalin is a natural thymic peptide Cytomax — broadest thymic peptide spectrum vs. Vilon's single dipeptide
  • 10-year human cohort showing approximately 2-fold mortality reduction in elderly subjects on annual courses
  • Mechanistic evidence for T-cell restoration, IL-2 upregulation, and CD4+/CD8+ normalization in cell and animal models
  • Used clinically in Russian gerontology practice for 30+ years with no serious adverse events documented
  • Characteristic 6–12 month aftereffect of Cytomax formulations — one course supports immune function well beyond the injection period
?UNCERTAIN
  • ?Whether Thymalin alone produces longevity benefit or requires combination with Epithalon and pineal compounds
  • ?Whether preventive use in younger adults (30s–50s) produces benefit before significant thymic involution
  • ?Optimal course length and frequency — 5-day annual is the best-supported but not the only studied protocol
  • ?Western-standard RCT data — all longevity data is from Khavinson's observational cohort
  • ?Mechanism of the 6–12 month aftereffect that is characteristic of Cytomax formulations
RECONSTITUTION CALCULATOR

EDUCATIONAL TOOL — NOT MEDICAL ADVICE · VERIFY WITH YOUR CLINICIAN

AI COACH PREVIEW
I want to start a Thymalin protocol. Should I run it alongside Epithalon, how long is the course, and what would a full annual cycle look like?
The classic Khavinson approach pairs Thymalin with Epithalon in a single annual course — typically done in spring. The standard protocol: Thymalin 5–10 mg/day SC for 5 days, concurrent with Epithalon 5–10 mg/day SC for 10 days. If you want to do two courses per year (spring and autumn), you can. The thymic benefit tends to accumulate over 3–4 annual courses based on Khavinson's cohort data. For a complete longevity stack, many biohackers add Vesugen (3 courses/year) and Endoluten (every 3–6 months) to address vascular and pineal aging simultaneously. Your individual course length should consider baseline immune markers if you have them — CD4/CD8 ratio, NK cell activity, and inflammatory markers are useful data points.
CONTINUE IN THE APP

Open PepperLedger to ask the Coach about the full thymic bioregulator stack →

Free to join. The Coach understands the full Khavinson system and can help you design a thymic restoration protocol for your age and goals.

Free to join · No credit card · 23-day Pro trial included

PepperLedger

Educational tool — not medical advice. PepperLedger is a logging and information tool for adults managing their own protocols. It does not prescribe, diagnose, or treat anything. Always work with a qualified healthcare provider for medical decisions.

Thymalin is a research compound used in Russian clinical practice but not FDA-approved. Most longevity evidence comes from the Khavinson group at the Saint Petersburg Institute of Bioregulation and Gerontology. The 10-year cohort is observational, not an RCT.

© 2026 Realee AI · PepperLedger